Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Licorice Aftin gel versus triamcinolone 0.1% for recurrent aphthous stomatitis in adults
IRCT20230430058027N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of triamcinolone in aphthosis (RAS) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Pain score, Duration of recovery and 2 more. Started Jul 2023; status: completed.
02
Drugs
triamcinolone
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on IRCT20230430058027N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230430058027N1.